𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Increased plasma ghrelin following infliximab in Crohn’s disease

✍ Scribed by E. Z. H. SUNG; N. F. DA SILVA; S. GOODYEAR; P. G. MCTERNAN; G. J. SANGER; C. U. NWOKOLO

Book ID
108605476
Publisher
John Wiley and Sons
Year
2009
Tongue
English
Weight
165 KB
Volume
29
Category
Article
ISSN
0269-2813

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Severe agranulocytosis following first i
Severe agranulocytosis following first infliximab infusion in Crohn's disease
✍ José Miguel Rosales-Zábal; Francisco Fernández-Pérez; Cristóbal Albandea-Moreno; 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 217 KB 👁 2 views

FIGURE 2. Granulocyte count during hospitalization. IFX: infliximab infusion. GR-CSF: introduction of granulocyte stimulating factor.

Infliximab dose intensification in Crohn
Infliximab dose intensification in Crohn's disease
✍ Miguel Regueiro; Benjamin Siemanowski; Kevin E. Kip; Scott Plevy 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 176 KB 👁 1 views

Background: Crohn's disease (CD) patients who lose response to infliximab may benefit from an increase in dose or decrease in interval between infusions. The aims of this study were to determine the proportion of CD patients who require dose intensification and factors associated with dose intensifi